Patients can prepare by being proactive: reviewing and adjusting insurance coverage, asking providers about alternatives, using discount programs, and stocking up when possible
The trials were registered at ClinicalTrials.gov (trial identifiers: NCT01037582 and NCT01686945, respectively)
Patients with severe gastrointestinal intolerance, medullary thyroid cancer history, pancreatitis risk, or dehydration concerns may require dose caps below 2.4 mg
However, growth slowed following the formulary change, increasing by just 0.02 percentage points from June to July and declining from July to August (0.02 points)
Slowed Stomach Emptying: Food stays in your Stomach longer, so you may eat smaller portions
GLP-1s are fantastic for insulin resistance